Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lauren P. Silvernail currently holds 5,248 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lauren P. Silvernail has been a net seller of RVNC stock. They have purchased $69.8K and sold $3.7M worth of shares.
Lauren P. Silvernail's most recent insider trade was on Jun 18, 2026, when they sold 5,248 shares at $0.00 per share.
Lauren P. Silvernail serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 103 insider transactions totaling $3.7M over their tenure at the company.
Lauren P. Silvernail holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Lauren P. Silvernail has shown a selling trading pattern, with $69.8K in total purchases and $3.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lauren P. Silvernail was on Mar 13, 2018, when they sold $892.4K worth of RVNC shares. This transaction involved 25,867 shares at $34.50 per share.
Lauren P. Silvernail currently owns 5,248 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lauren P. Silvernail's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lauren P. Silvernail has 103 Form 4 filings on record as an insider at Revance Therapeutics, Inc..
Set alerts for Lauren P. Silvernail and 40,000+ other insiders.